Page last updated: 2024-08-17

triamcinolone acetonide and almagate

triamcinolone acetonide has been researched along with almagate in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (55.56)29.6817
2010's8 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Menéndez de Lucas, JA; Morcillo Laiz, R1
Bandello, F; Chakravarthy, U; Chong, V; Creuzot-Garcher, C; Dimitrakos, SA; Korobelnik, JF; Larsen, M; Monés, J; Pauleikhoff, D; Pournaras, CJ; Soubrane, G; Staurenghi, G; Virgili, G; Wolf, S1
Chaudhry, NA; Colina, J; Haffner, G; Liggett, PE; Tom, D1
Bienias, W; Nowak, JZ1
Criswell, MH; Hu, WZ; Li, R; Margaron, P; Steffens, TJ1
Covert, DJ; Hur, EY; Kim, JE; Mantravadi, AV1
Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A1
Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Spital, G; Zeimer, M1
Cohen, SY; Nghiem-Buffet, S1
Gelisken, F; Ziemssen, F1
Agostini, H; Bertram, B; Feltgen, N; Hansen, L; Hoerauf, H; Jaissle, GB; Pielen, A; Stahl, A1
Cennamo, G; Cesarano, I; D'Amico, G; De Crecchio, G; Finelli, M; Forte, R1
Brown, DM; Chen, E; Cox, J; Lin, MY1
Grabska-Liberek, I; Jamrozy-Witkowska, A; Jankowska-Lech, I; Kowalska, K; Nowosielska, A; Terelak-Borys, B1
Fraser-Bell, S; Gillies, M; Salem, W1
Chen, TC; Englander, M; Kim, IK; Miller, JW; Paschalis, EI1
García-Campos, JM; López-Gálvez, MI1

Reviews

6 review(s) available for triamcinolone acetonide and almagate

ArticleYear
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies].
    Postepy higieny i medycyny doswiadczalnej (Online), 2007, Volume: 61

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Bevacizumab; Humans; Lipofuscin; Macular Degeneration; Neovascularization, Pathologic; Photochemotherapy; Pregnadienediols; Ranibizumab; Retinal Drusen; Triamcinolone Acetonide

2007
[Retinal vein occlusion: anti-VEGF treatments].
    Journal francais d'ophtalmologie, 2009, Volume: 32, Issue:9

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Blood-Retinal Barrier; Clinical Trials as Topic; Humans; Macular Edema; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity

2009
[Diabetic maculopathy. Diagnosis and treatment].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2010, Volume: 107, Issue:8

    Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Glycated Hemoglobin; Humans; Intravitreal Injections; Ischemia; Laser Coagulation; Macular Edema; Ophthalmoscopy; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A

2010
[Intravitreal drug therapy for retinal vein occlusion--pathophysiological mechanisms and routinely used drugs].
    Klinische Monatsblatter fur Augenheilkunde, 2010, Volume: 227, Issue:9

    Topics: Adrenal Cortex Hormones; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Blood Flow Velocity; Cell Division; Combined Modality Therapy; Dexamethasone; Endothelium, Vascular; Erythropoietin; Hemodilution; Humans; Intravitreal Injections; Laser Coagulation; Long-Term Care; Papilledema; Prognosis; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Artery; Retinal Vein; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A

2010
Clinical development of new treatments for diabetic macular oedema.
    Clinical & experimental optometry, 2012, Volume: 95, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Cataract Extraction; Dexamethasone; Diabetic Retinopathy; Humans; Laser Coagulation; Macular Edema; Pregnadienetriols; Tomography, Optical Coherence; Triamcinolone Acetonide

2012
[From scientific evidence to clinical practice: treatment protocols for diabetic macular edema].
    Archivos de la Sociedad Espanola de Oftalmologia, 2012, Volume: 87 Suppl 1

    Topics: Algorithms; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Clinical Protocols; Diabetic Retinopathy; Drug Approval; European Union; Fluorescein Angiography; Humans; Laser Coagulation; Macular Edema; Microscopy, Acoustic; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Tomography, Optical Coherence; Translational Research, Biomedical; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A

2012

Other Studies

12 other study(ies) available for triamcinolone acetonide and almagate

ArticleYear
[Medical and legal issues related to the drugs currently used in the treatment of Age-Related Macular Degeneration (ARMD)].
    Archivos de la Sociedad Espanola de Oftalmologia, 2006, Volume: 81, Issue:7

    Topics: Aptamers, Nucleotide; Drug Utilization; Humans; Macular Degeneration; Photosensitizing Agents; Porphyrins; Spain; Triamcinolone Acetonide; Verteporfin

2006
Evolving European guidance on the medical management of neovascular age related macular degeneration.
    The British journal of ophthalmology, 2006, Volume: 90, Issue:9

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Evidence-Based Medicine; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Treatment Outcome; Triamcinolone Acetonide

2006
Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization.
    American journal of ophthalmology, 2006, Volume: 142, Issue:6

    Topics: Aged, 80 and over; Aptamers, Nucleotide; Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity; Vitreous Body

2006
[Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration].
    Klinische Monatsblatter fur Augenheilkunde, 2007, Volume: 224, Issue:7

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Macular Degeneration; Ophthalmology; Photochemotherapy; Porphyrins; Pregnadienediols; Ranibizumab; Societies, Medical; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin

2007
Comparing pegaptanib and triamcinolone efficacy in the rat choroidal neovascularization model.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Aptamers, Nucleotide; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Injections; Laser Coagulation; Male; Rats; Rats, Inbred BN; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body

2008
Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.
    American journal of ophthalmology, 2008, Volume: 146, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Drug Monitoring; Female; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ranibizumab; Retinal Diseases; Retrospective Studies; Time Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body

2008
[Intravitreous injection: retrospective study on 2028 injections and their side effects].
    Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:7

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage

2008
Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments.
    Eye (London, England), 2009, Volume: 23, Issue:12

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Immunologic Factors; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Pigment Epithelium of Eye; Ranibizumab; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity

2009
Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization.
    Acta ophthalmologica, 2010, Volume: 88, Issue:8

    Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Prognosis; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity

2010
Endophthalmitis after intravitreal injection: the importance of viridans streptococci.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Diseases; Retrospective Studies; Risk Factors; Streptococcal Infections; Triamcinolone Acetonide; Viridans Streptococci; Visual Acuity; Vitreous Body

2011
[Complications of intravitreal injections--own experience].
    Klinika oczna, 2011, Volume: 113, Issue:4-6

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctival Diseases; Diabetic Retinopathy; Endophthalmitis; Eye Diseases; Eye Hemorrhage; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Iris Diseases; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Poland; Ranibizumab; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity

2011
Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
    The British journal of ophthalmology, 2013, Volume: 97, Issue:4

    Topics: Academic Medical Centers; Acute Disease; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Male; Massachusetts; Postoperative Complications; Ranibizumab; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity

2013
chemdatabank.com